Vape cartridges represent a significant share of pan-cannabis markets.  Traditional ∆9-THC products have comprised the bulk of the market until the ∆8-THC phenomenon swept across the US like a virus in a hot yoga class. 

These estimates, and others like them, do not factor in the massive volume transacted to satisfy a seemingly endless demand for ∆8 distillate, the first novel cannabinoid to be mass marketed throughout the US.  This of course isn’t the first market explosion for cannabinoid-laden vape cartridges.  The public health fallout from widespread use of illicit MJ cartridges formulated with Vitamin E Acetate revealed the extent to which they’d penetrated the US market. 

In